Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
It's A List! Why Is China's Rare Disease List A Major Milestone For Orphan Drug Developers?
May 30 2018
•
By
Brian Yang
China's first rare disease list a major step for orphan drug developers
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from China
More from Asia